STOCK TITAN

Dominari Holdings (NASDAQ: DOMH) tweaks warrants, brings in $3.67M cash

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Dominari Holdings Inc. entered into Inducement Agreements with holders of its Series B warrants to adjust terms and encourage early exercise or exchange. The warrants originally allowed purchase of up to 3,133,880 shares of common stock at an exercise price of $4.22 per share.

Holders could either exercise their existing warrants for cash at a reduced price of $2.50 per share (Option A) or exchange all unexercised warrants for common stock at a 10:3 ratio without additional cash (Option B). The company expects to receive approximately $3.67 million of gross proceeds from Option A elections and to issue about 150,000 shares under Option B, with roughly 1.2 million Series B warrants remaining unexercised. The Option B exchange shares were issued under a Section 3(a)(9) exemption from registration.

Positive

  • None.

Negative

  • None.

Insights

Dominari trades near-term dilution and warrant revisions for immediate cash proceeds.

Dominari Holdings restructured its Series B warrants by offering a lower cash exercise price and a warrant-for-share exchange. This brings in about $3.67 million in cash while also cancelling some warrants through the 10:3 exchange feature.

The move reduces potential long-term warrant overhang but adds new common shares now via both exercised and exchanged warrants. Around 1.2 million Series B warrants will still remain outstanding, so future exercises are still possible. Overall impact depends on the company’s cash needs and how the added float interacts with market demand.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Series B warrant coverage 3,133,880 shares Common stock underlying Series B warrants
Original exercise price $4.22 per share Exercise price of existing Series B warrants
Reduced exercise price $2.50 per share Cash exercise price under Option A
Expected gross proceeds $3.67 million From Option A warrant cash exercises
Option B share issuance 150,000 shares Approximate common shares issued via 10:3 exchange
Remaining unexercised warrants 1.2 million warrants Estimated unexercised Series B warrants after transactions
Inducement Agreements financial
"entered into inducement agreements (the “Inducement Agreements”) with certain holders"
Series B warrants financial
"holders (the “Holders”) of Series B warrants (the “Series B Warrants”) of the Company"
Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.
market overhang financial
"in a successful effort to reduce market overhang from outstanding warrants"
Market overhang is the expectation that a sizable block of a company's shares or related securities will soon become available for sale, adding extra supply that can pressure the stock price. Examples include shares held by insiders, shares locked up after an offering, or convertible debt that can turn into stock. Investors watch overhang because uncertainty about when and how much will hit the market can increase price swings, make gains harder to sustain, and complicate valuation—like a cloud that may dim demand until it passes.
Section 3(a)(9) regulatory
"issued in reliance upon the exemption from registration provided by Section 3(a)(9) of the Securities Act"
Section 3(a)(9) is a provision of U.S. securities law that exempts certain exchanges of an issuer’s own securities with its existing holders from the usual public registration rules, typically when the swap doesn’t involve a public offering or outside buyers. For investors, it matters because such exchanges can change who holds what, affect dilution and liquidity, and may occur with less public disclosure than a registered sale — think of it like swapping old coupons for new ones behind the scenes rather than selling them in a public marketplace.
registration statement on Form S-3 regulatory
"registered for resale pursuant to an effective registration statement on Form S-3 (No. 333-286648)"
A registration statement on Form S‑3 is a short, standardized filing a qualified public company uses to register new securities with regulators so they can be sold to investors; think of it as a pre-approved, reusable permission slip that speeds up future offerings. It matters to investors because it lets the company raise money more quickly and cheaply — which can fund growth or pay debt — but may also lead to share dilution or change in ownership, so it affects value and liquidity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Dominari Holdings Inc. (DOMH) announce regarding its Series B warrants?

Dominari Holdings entered into Inducement Agreements with Series B warrant holders to encourage early exercise or exchange. Holders can either exercise for cash at a reduced price or exchange all remaining warrants for common stock using a fixed 10-for-3 share ratio.

How much cash does Dominari Holdings (DOMH) expect from the warrant inducement?

The company expects gross proceeds of about $3.67 million from Option A, where holders exercise Series B warrants for cash at $2.50 per share. This provides immediate funding while simultaneously reducing part of the outstanding warrant overhang disclosed in the agreement.

What are the key terms of Option A and Option B in Dominari’s Inducement Agreements?

Under Option A, holders may exercise existing Series B warrants for cash at $2.50 per share. Under Option B, they can exchange all unexercised warrants for common stock at a 10:3 ratio, receiving three shares for every ten underlying warrant shares without paying additional cash.

How many shares and warrants are affected in Dominari Holdings’ warrant transaction?

The original Series B warrants cover up to 3,133,880 common shares at $4.22 per share. Dominari expects to issue about 150,000 shares under Option B and estimates around 1.2 million Series B warrants will remain unexercised after the inducement transactions are completed.

How were Dominari Holdings’ Option B exchange shares issued from a regulatory standpoint?

The shares of common stock issued under Option B, called Exchange Shares, were issued without additional cash consideration. Dominari relied on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933 for this warrant-for-share exchange.

Are the shares underlying Dominari’s existing Series B warrants already registered for resale?

Yes. The common shares underlying the existing Series B warrants are registered for resale under an effective registration statement on Form S-3, file number 333-286648, which was filed with the SEC on April 21, 2025 and declared effective on April 25, 2025.
false 0000012239 0000012239 2026-05-22 2026-05-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 22, 2026

 

Dominari Holdings Inc.

 

(Exact name of registrant as specified in its charter)

 

Delaware   001-41845   52-0849320
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

725 5th Avenue, 22nd Floor

New York, NY 10022

(212) 393-4540

(Address, including Zip Code and Telephone Number, including

Area Code, of Principal Executive Offices)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value   DOMH   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement. 

 

On May 22, 2026, Dominari Holdings Inc. (the “Company”), a Delaware corporation, in a successful effort to reduce market overhang from outstanding warrants, entered into inducement agreements (the “Inducement Agreements”) with certain holders (the “Holders”) of Series B warrants (the “Series B Warrants”) of the Company to purchase up to an aggregate of 3,133,880 shares of the Company’s Common Stock, par value $0.0001 per share (“Common Stock”), originally issued to the Holders in connection with the Company’s previous originally issued to the Holders on February 14, 2025, having an original exercise price of $4.22 per share (the “Existing Warrants”). The shares of Common Stock issuable upon exercise of the Existing Warrants are registered for resale pursuant to an effective registration statement on Form S-3 (No. 333-286648) previously filed with the U.S. Securities and Exchange Commission (“SEC”) on April 21, 2025, and declared effective by the SEC on April 25, 2025.

 

Pursuant to the Inducement Agreements, the Holders were offered options to either (A) exercise for cash their Existing Warrants at a reduced exercise price of $2.50 per share (“Option A”) or (B) exchange all, but not less than all, of such Holder’s unexercised Existing Warrants for shares of Common Stock at an exchange ratio of 10:3, such that for every ten shares of Common Stock underlying the exchanged Series B Warrants, the Company would issue three shares of Common Stock (the “Exchange Shares”) for no additional consideration (“Option B”). The Exchange Shares were issued in reliance upon the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended.

 

The Company expects to receive gross proceeds of approximately $3.67 million pursuant to Option A elections by Holders and expects to issue approximately 150,000 shares of Common Stock pursuant to Option B elections by Holders. Following entry into the Inducement Agreements and consummation of the related issuances and payments, the Company expects there to be approximately 1.2 million unexercised Series B Warrants outstanding.

 

The foregoing summaries of the Inducement Agreements do not purport to be complete and are subject to, and qualified in their entirety by, the form of such document attached as Exhibits 10.1 to this Current Report on Form 8-K, which are incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit   Description
10.1   Form of Inducement Agreement.
104   Cover Page Interactive Data File (formatted as Inline XBRL)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 27, 2026 DOMINARI HOLDINGS INC.
     
  By: /s/ Anthony Hayes
  Name:  Anthony Hayes
  Title: Chief Executive Officer

 

2

 

Filing Exhibits & Attachments

4 documents